Page last updated: 2024-11-02

pioglitazone and Cataract

pioglitazone has been researched along with Cataract in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Treatment of pioglitazone also protected the secondary structural alterations induced by glycation and inhibited the formation of protein aggregates."5.72Ameliorative effect of pioglitazone on glucose induced glycation of α-crystallin: Management of complications associated with diabetic retinopathy. ( Ren, Z; Song, J, 2022)
"Treatment of pioglitazone also protected the secondary structural alterations induced by glycation and inhibited the formation of protein aggregates."1.72Ameliorative effect of pioglitazone on glucose induced glycation of α-crystallin: Management of complications associated with diabetic retinopathy. ( Ren, Z; Song, J, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ren, Z1
Song, J1

Other Studies

1 other study available for pioglitazone and Cataract

ArticleYear
Ameliorative effect of pioglitazone on glucose induced glycation of α-crystallin: Management of complications associated with diabetic retinopathy.
    International journal of biological macromolecules, 2022, Jun-01, Volume: 209, Issue:Pt A

    Topics: alpha-Crystallins; Cataract; Crystallins; Diabetes Mellitus; Diabetic Retinopathy; Glucose; Humans;

2022